Tenet Healthcare Corp (THC) Stock Analysis
Verdict: BUY
Structural pivot to high-margin ambulatory care (ASCs) drives record FCF and earnings beats, offsetting leverage and policy headwinds.
Investment score: 74/100
Analysis as of
Is Tenet Healthcare Corp stock worth reviewing? The TradeMates thesis
THC is characterized by strong fundamental momentum and attractive relative valuation, though high leverage requires monitoring.
7-factor investment score
- Valuation: 82/100 (weight 20%)
- Financial Health: 70/100 (weight 15%)
- Technical Momentum: 65/100 (weight 15%)
- Earnings Quality: 90/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 75/100 (weight 15%)
Tenet Healthcare Corp opportunities and risks
What speaks for THC
- Ambulatory Margin Expansion
What speaks against THC
- Reimbursement Rate Sensitivity
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| THC | 8.9x | 0.9x | 6.2x | 26.9% | 10.3% | 15.0% |
| HCA | 12.8x | 1.1x | 8.4x | 28.4% | 8.8% | 7.1% |
| EHC | 18.6x | 1.8x | 9.5x | 58.8% | 10.0% | 4.1% |
| ENSG | 26.3x | 1.8x | 19.4x | 15.4% | 6.9% | 4.1% |
| UHS | 6.5x | 0.5x | 5.3x | 71.3% | 8.6% | 9.2% |
| PACS | 30.2x | 1.4x | 24.0x | 19.2% | 4.5% | 3.2% |
| Peer median | 18.6x | 1.4x | 9.5x | 28.4% | 8.6% | 4.1% |
Frequently asked questions about Tenet Healthcare Corp (THC)
Is THC stock a good investment?
The TradeMates model rates Tenet Healthcare Corp as BUY with an investment score of 74/100. THC is characterized by strong fundamental momentum and attractive relative valuation, though high leverage requires monitoring. This is algorithmic model output, not personal investment advice.
Is THC stock a buy?
The TradeMates model verdict for THC is BUY with an investment score of 74/100. Treat this as a model signal to review, not a personal buy recommendation.